Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.

PURPOSE Risk factors for local and distant recurrence after breast-conserving therapy and mastectomy were compared to define guidelines for the decision making between both treatments. PATIENTS AND METHODS The data of two randomized clinical trials for stage I and II breast cancer patients were pooled. The total number of patients in the study was 1,772, of whom 879 underwent breast conservation, and 893, modified radical mastectomy. Representative slides of the primary tumor were available for histopathologic review in 1,610 cases (91%). RESULTS There were 79 patients with local recurrence after breast-conservation and 80 after mastectomy, the 10-year rates being 10% (95% confidence interval [CI], 8% to 13%) and 9% (95% CI, 7% to 12%), respectively. Age no more than 35 years (compared with age >60: hazard ratio [HR], 9.24; 95% CI, 3.74 to 22.81) and an extensive intraductal component (HR, 2.52; 95% CI, 1.26 to 5.00) were significantly associated with an increased risk of local recurrence after breast-conserving therapy. Vascular invasion was predictive of the risk of local recurrence, irrespective of the type of primary treatment (P <.01). Tumor size, nodal status, high histologic grade, and vascular invasion were all highly significant predictors of distant disease after breast-conserving therapy and mastectomy (P <.01). Age no more than 35 years and microscopic involvement of the excision margin were additional independent predictors of distant disease after breast-conserving therapy (P <.01). CONCLUSION Age no more than 35 years and the presence of an extensive intraductal component are associated with an increased risk of local recurrence after breast-conserving therapy. Vascular invasion causes a higher risk of local recurrence after mastectomy as well as after breast-conserving therapy and should therefore not be used for deciding between the two treatments.

[1]  H. Bartelink,et al.  Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. , 1992, European journal of cancer.

[2]  D. Schultz,et al.  The influence of young age on outcome in early stage breast cancer. , 1994, International journal of radiation oncology, biology, physics.

[3]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[4]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[5]  C. Hill,et al.  Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave‐roussy , 1984, Cancer.

[6]  H. Høst,et al.  Age as a prognostic factor in breast cancer , 1986, Cancer.

[7]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[8]  A. Luini,et al.  Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast , 1981 .

[9]  M. J. van de Vijver,et al.  Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) , 1999, European journal of cancer.

[10]  S. Schnitt,et al.  Pathologic findings on re‐excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy , 1987, Cancer.

[11]  S. Schnitt,et al.  Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy , 1984, Cancer.

[12]  R. Weichselbaum,et al.  Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. , 1996, Journal of the National Cancer Institute.

[13]  D. Fischer,et al.  Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[15]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[16]  Anthony Howell,et al.  Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. , 1995, The New England journal of medicine.

[17]  E. van Limbergen,et al.  Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  A Lichter,et al.  Results of the National Cancer Institute early breast cancer trial. , 1992, Journal of the National Cancer Institute. Monographs.

[19]  J. Jacquemier,et al.  Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy , 1990, Cancer.

[20]  S J Schnitt,et al.  The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy , 1994, Cancer.

[21]  B. Asselain,et al.  Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.

[22]  P. Wingo,et al.  Long-term cancer patient survival in the United States. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  C. Redmond,et al.  Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. , 1992, Seminars in surgical oncology.

[24]  A. Hart,et al.  Risk factors in breast-conservation therapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  C. Bressac,et al.  Mammary recurrences in women younger than forty. , 1988, International journal of radiation oncology, biology, physics.

[26]  P Okunieff,et al.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. , 1995, The New England journal of medicine.

[27]  P. Andersen,et al.  Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.

[28]  R. Arriagada,et al.  Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  R Holland,et al.  The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Nixon,et al.  Relationship of patient age to pathologic features of the tumor and the risk of local recurrence for for patients with stage I or II breast cancer treated with conservative surgery and radiation therapy , 1992 .

[31]  D. Stea,et al.  Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. , 1996, American journal of surgery.

[32]  A. Howell,et al.  Lobular carcinoma of the breast can be managed by breast‐conserving therapy , 1995, The British journal of surgery.

[33]  C. Coleman,et al.  Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. , 1989, International journal of radiation oncology, biology, physics.

[34]  S. Hellman,et al.  Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy? , 1986, Cancer.

[35]  S Friedman,et al.  The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  B Fisher,et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.

[37]  S. Schnitt,et al.  Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. , 1987, Archives of surgery.

[38]  D. Neuberg,et al.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  R. Arriagada,et al.  Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (institut gustave roussy 1970–1982) , 1995, Cancer.

[40]  Allan Tucker,et al.  Local Failure and Margin Status in Early‐Stage Breast Carcinoma Treated with Conservation Surgery and Radiation Therapy , 1993, Annals of surgery.

[41]  E Marubini,et al.  Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.

[42]  A. Vincent-Salomon,et al.  Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns , 1996, Cancer.

[43]  F. Vicini,et al.  Long term results with breast‐conserving therapy for patients with early stage breast carcinoma in a community hospital setting , 1998, Cancer.

[44]  P. Vielh,et al.  Local control and survival of breast cancer treated by limited surgery followed by irradiation. , 1986, International journal of radiation oncology, biology, physics.

[45]  I. Gage,et al.  Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast‐conserving therapy , 1996, Cancer.

[46]  J. Peterse,et al.  Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. , 1999, European journal of cancer.

[47]  N. Weidner,et al.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[49]  C. Redmond,et al.  Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. , 1995, New England Journal of Medicine.

[50]  A. Luini,et al.  Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. , 1986, European journal of cancer & clinical oncology.

[51]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[52]  H. Mouridsen,et al.  Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. , 1992, Journal of the National Cancer Institute. Monographs.

[53]  F. Ames,et al.  Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer , 1989, Cancer.